Cantor Fitzgerald Forecasts Centene FY2025 Earnings

Centene Co. (NYSE:CNC) – Equities research analysts at Cantor Fitzgerald issued their FY2025 earnings estimates for Centene in a report issued on Tuesday, January 21st. Cantor Fitzgerald analyst S. James anticipates that the company will post earnings of $7.27 per share for the year. Cantor Fitzgerald has a “Overweight” rating and a $90.00 price objective on the stock. The consensus estimate for Centene’s current full-year earnings is $6.81 per share.

Several other equities research analysts also recently commented on CNC. Robert W. Baird decreased their price objective on Centene from $83.00 to $66.00 and set a “neutral” rating for the company in a report on Friday, October 25th. UBS Group upgraded Centene from a “neutral” rating to a “buy” rating and lifted their price target for the company from $79.00 to $80.00 in a research note on Friday, December 13th. StockNews.com downgraded Centene from a “strong-buy” rating to a “buy” rating in a research note on Monday, October 28th. Stephens decreased their price target on Centene from $75.00 to $73.00 and set an “equal weight” rating for the company in a report on Friday, December 13th. Finally, Barclays boosted their price target on shares of Centene from $91.00 to $93.00 and gave the stock an “overweight” rating in a report on Friday, December 13th. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and ten have issued a buy rating to the stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $80.92.

Centene Stock Performance

Shares of Centene stock opened at $63.56 on Wednesday. The business has a 50-day simple moving average of $60.25 and a 200 day simple moving average of $67.28. Centene has a one year low of $55.03 and a one year high of $81.42. The company has a debt-to-equity ratio of 0.64, a current ratio of 1.10 and a quick ratio of 1.10. The firm has a market capitalization of $32.09 billion, a price-to-earnings ratio of 11.03, a PEG ratio of 0.83 and a beta of 0.45.

Insider Buying and Selling at Centene

In other Centene news, CFO Andrew Lynn Asher bought 17,200 shares of Centene stock in a transaction that occurred on Wednesday, November 13th. The stock was acquired at an average cost of $58.14 per share, for a total transaction of $1,000,008.00. Following the completion of the transaction, the chief financial officer now directly owns 486,847 shares in the company, valued at $28,305,284.58. This represents a 3.66 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through this link. Also, CEO Sarah London acquired 4,117 shares of the firm’s stock in a transaction that occurred on Friday, November 8th. The stock was bought at an average price of $60.80 per share, for a total transaction of $250,313.60. Following the completion of the transaction, the chief executive officer now owns 667,229 shares of the company’s stock, valued at $40,567,523.20. The trade was a 0.62 % increase in their position. The disclosure for this purchase can be found here. Insiders have bought a total of 45,010 shares of company stock worth $2,660,276 over the last ninety days. 0.29% of the stock is currently owned by company insiders.

Institutional Trading of Centene

A number of hedge funds have recently made changes to their positions in the stock. Park Place Capital Corp boosted its stake in shares of Centene by 1,190.0% in the 3rd quarter. Park Place Capital Corp now owns 387 shares of the company’s stock valued at $29,000 after purchasing an additional 357 shares in the last quarter. Private Trust Co. NA boosted its position in Centene by 75.3% during the third quarter. Private Trust Co. NA now owns 773 shares of the company’s stock valued at $58,000 after buying an additional 332 shares during the period. True Wealth Design LLC purchased a new position in shares of Centene in the third quarter worth about $66,000. EverSource Wealth Advisors LLC lifted its stake in shares of Centene by 104.8% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,231 shares of the company’s stock valued at $82,000 after acquiring an additional 630 shares during the last quarter. Finally, Venturi Wealth Management LLC grew its position in Centene by 77.3% during the 3rd quarter. Venturi Wealth Management LLC now owns 1,163 shares of the company’s stock worth $88,000 after acquiring an additional 507 shares during the last quarter. 93.63% of the stock is owned by institutional investors.

Centene Company Profile

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children’s health insurance program, foster care, medicare-medicaid plans, long-term services and support.